France Medical Cannabis Market, by Product Type

Growth Outlook

• The France Medical Cannabis Market, by Product Type market is on a steady long-term growth path. Segment value stands at roughly USD 1083 Mn in 2026 and is projected to reach USD 1474 Mn by 2027 — a gain of about 36% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Dissolvables/Powders leads, holding roughly 44% of segment value — the single largest regional share. Oil is the second-largest contributor. Solids and Ointments & Creams make up the remainder, in descending order.
• By 2027, Dissolvables/Powders alone is expected to reach USD 642 Mn, with Oil at USD 527 Mn.

Market Dynamics

The demand for medical cannabis in France has been growing steadily in recent years. This trend can be attributed to the increasing acceptance of cannabis as a legitimate medical treatment, as well as the rising number of patients seeking alternative therapies for a variety of health conditions.

One of the primary reasons for the demand of medical cannabis in France is its potential to alleviate symptoms of chronic pain. Many patients suffering from conditions such as arthritis, multiple sclerosis, and fibromyalgia have reported finding relief with medical cannabis, leading to an increase in demand for the product.

Another product type that is in high demand in the French medical cannabis market is CBD oil. This non-psychoactive component of cannabis has gained popularity due to its potential therapeutic benefits. Many users have reported finding relief from anxiety, depression, and insomnia with the use of CBD oil. Additionally, CBD has also been touted for its anti-inflammatory properties, making it a sought-after product for those suffering from chronic pain and inflammation.

In addition to its potential for pain management, medical cannabis is also being increasingly used to treat symptoms of neurological disorders such as epilepsy, Parkinson's disease, and Tourette syndrome. CBD, in particular, has shown promising results in reducing the frequency and severity of seizures in patients with epilepsy. This has led to a surge in demand for CBD-based products in the French market.

There has also been a growing interest in medical cannabis as a potential treatment for mental health conditions such as post-traumatic stress disorder (PTSD), depression, and anxiety. Preliminary research has shown that cannabis may have a positive impact on these conditions, leading to an increase in demand for medical cannabis products in France.

Furthermore, the rise in popularity of natural and alternative medicine has also contributed to the demand for medical cannabis in France. Many patients are turning away from traditional pharmaceuticals and seeking out more natural and holistic treatment options, with medical cannabis being one of them.

In conclusion, the demand for medical cannabis in France is being driven by various factors such as its potential for pain relief, treatment of neurological and mental health conditions, and its natural and holistic nature. As more research is conducted on the therapeutic benefits of cannabis, it is expected that the demand for medical cannabis will continue to grow in France.